Using homeostatic peptides in decompensated heart failure a reasonable paradigm but a flawed practice?
- PMID: 17980249
- DOI: 10.1016/j.jacc.2007.07.052
Using homeostatic peptides in decompensated heart failure a reasonable paradigm but a flawed practice?
Comment on
-
Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.J Am Coll Cardiol. 2007 Nov 6;50(19):1835-40. doi: 10.1016/j.jacc.2007.03.071. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980248 Clinical Trial.
Similar articles
-
Effect of nesiritide on renal function in patients admitted for decompensated heart failure.QJM. 2007 Nov;100(11):699-706. doi: 10.1093/qjmed/hcm089. QJM. 2007. PMID: 17971392
-
Impact of ultrafiltration on renal function in patients with decompensated heart failure.Congest Heart Fail. 2009 Jul-Aug;15(4):210-1. doi: 10.1111/j.1751-7133.2009.00090.x. Congest Heart Fail. 2009. PMID: 19627301 No abstract available.
-
Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.J Am Coll Cardiol. 2007 Nov 6;50(19):1835-40. doi: 10.1016/j.jacc.2007.03.071. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980248 Clinical Trial.
-
Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.Pharmacotherapy. 2007 May;27(5):619-25. doi: 10.1592/phco.27.5.619. Pharmacotherapy. 2007. PMID: 17461695 Review.
-
[Nesiritide in heart failure: commercial success or therapeutic advance?].Rev Med Suisse. 2006 Jan 25;2(50):295-8. Rev Med Suisse. 2006. PMID: 16503047 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
